Scientists from the Perron Institute of Neurology and Translational Sciences in Western Australia and Murdoch University have found new ways to treat Parkinson’s disease. To do this, they propose to pay attention to the genetic processes that cause the degeneration of nerve cells in patients. An article with the findings of the study was published in the journal Experimental Biology and Medicine.
In the course of the work, the specialists analyzed the introns that affect DNA sequencing and revealed their impact on the development of Parkinson’s disease. It turned out that they can be indicators of the risk of occurrence and progression of the disease.
Earlier research has focused on exons, which make up two percent of the human genome, responsible for encoding protein information. The bulk of the risk of developing a neurodegenerative disease is concentrated in the remaining 98 percent, which determines where, when, and how exons are produced. Scientists believe that their discovery will allow the formation of new methods of therapy, diagnosis and prevention of Parkinson’s disease.
In June, doctors at the University of Kiel in Germany proposed a new method that can detect Parkinson’s disease based on the analysis of protein changes in the blood.